Reports Q4 revenue $6.34M, consensus $6.42M. “We have started a milestone rich year in which we will demonstrate the tangible reality of our overall strategic transformation into a company with an easily adopted robot that can navigate a proprietary set of catheters in EP and broadly across endovascular procedures,” said David Fischel, Chairman and CEO.
Education
About Us
Working with TipRanks
Follow Us
1